Indications of tinnitus reliever in Japan

Japanese Tinnitus Relief Agent is a compound preparation for tinnitus caused by dysfunction of the inner ear and central nervous system. It is developed and produced by Nippon Shine Co., Ltd. The main ingredients of the drug are nicotinamide and pipebatonium hydrochloride, which exert therapeutic effects by improving inner ear microcirculation and regulating nerve function. The article will introduce in detail the scope of application, treatment principle and usage limitations of the drug from three aspects: indications, efficacy and effects, and contraindications.

Indications of Japanese Tinnitus Relief Agents

Japanese Tinnitus Relief Agents are suitable for specific types of tinnitus symptoms. Clear indications are the prerequisite for rational drug use. Japanese tinnitus reliever is a medicine that targets tinnitus caused by disorders in the middle area of ​​the inner ear membrane. When using it, you should also follow the guidance of your doctor and pay attention to the validity period and side effects of the medicine.

Inner ear dysfunctional tinnitus

This drug mainly targets tinnitus caused by disorders in the middle area of ​​the inner ear membrane. This type of tinnitus often manifests as persistent high-frequency ringing, accompanied by slight hearing loss or ear fullness.

Central nervous system-related tinnitus

For tinnitus caused by abnormal signal processing in the central auditory pathway, drugs may improve symptoms by regulating neurotransmitters, especially for tinnitus induced by long-term stress or fatigue.

Vascular tinnitus

Pulsatile tinnitus associated with inner ear microcirculatory disturbances may respond to treatment, with medications relieving symptoms by improving local blood flow.

Accurate identification of indication types can help improve treatment effects and avoid blind medication.

Efficacy and role of tinnitus reliever in Japan

Understanding the mechanism of action of the drug will help to understand its therapeutic effect and limitations.

Improve the microcirculation of the inner ear

The component of pipebatonium hydrochloride has a vasodilatory effect, which can increase the capillary blood flow of the inner ear, improve the ischemic state, and reduce tinnitus caused by insufficient blood supply.

Neuromodulatory effect

Nicotinamide participates in neurometabolism as a coenzyme component and may reduce the intensity of tinnitus perception by regulating the abnormal excitability of the central auditory pathway.

Symptom relief characteristics

Clinical observation shows that after regular use for 2-4 weeks, most patients report a reduction in tinnitus loudness or frequency of attacks, and the effect is more significant on early-stage, functional tinnitus.

Understanding the action characteristics of drugs can help establish reasonable treatment expectations and formulate personalized medication plans.

Contraindications of tinnitus relievers in Japan

Patients should clearly understand the contraindications before taking the medicine. If there are contraindications, they should not use the medicine at will.

Absolute contraindications

It is prohibited for patients with glaucoma because the drug may increase intraocular pressure and aggravate the condition. It is prohibited to be used by patients with severe liver damage as it may affect drug metabolism.

Relative contraindications

Patients with atrioventricular block should use it with caution, as the drug may induce arrhythmia. Patients with hypotension should take medication under monitoring to prevent further reduction in blood pressure.

Pregnant women should only consider using it if the benefits clearly outweigh the risks. Safety in children has not been established, and the elderly need to reduce the dose and closely monitor adverse reactions.